Streetbeat News

Regulatory

HPE

Hewlett Packard Enterprise (HPE) has announced a planned segment re-alignment, which is expected to become effective on November 1, 2023. The company's organizational structure will remain unchanged for the rest of fiscal 2023, with the CEO continuing to evaluate the business under the existing structure. The new segment structure will be reported from the first quarter of fiscal 2024.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:25 pm

BIP

TRTN

Brookfield Infrastructure Partners L.P. (BIP) and Triton International Limited (TRTN) have received all necessary regulatory approvals for their proposed acquisition. The transaction is expected to close on September 28, 2023. Triton shareholders have until September 26, 2023 to elect their preferred form of merger consideration. The options include a mix of cash and BIPC shares, all cash, or all BIPC shares.

Portfolio Pulse from Happy Mohamed

September 19, 2023 | 8:16 pm

PXDT

Pixie Dust Technologies has received a notice of delinquency due to a delay in filing its Form 20-F.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:16 pm

SOND

Sonder Holdings has announced plans for a 1-for-20 reverse stock split in an effort to regain compliance with Nasdaq listing requirements.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:07 pm

NHWK

Nighthawk Biosciences has approved a refocus and restructuring plan to shed non-core assets and reduce operating costs, according to an SEC filing on September 18, 2023.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:05 pm

TSHA

Taysha Gene Therapies has decided to discontinue the development of its TSHA-120 program for the treatment of Giant Axonal Neuropathy (GAN) following feedback from the U.S. FDA. The decision was made due to challenges with study design feasibility for potential Biologics License Application (BLA) submission. Additionally, Astellas Gene Therapies has chosen not to exercise its option to obtain an exclusive license to TSHA-120 under the Option Agreement.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:03 pm

ATRA

Atara Biotherapeutics has announced its plans to submit a Biologics License Application (BLA) for Tab-cel in Q2 2024. This decision follows an agreement with the FDA on comparability.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:02 pm

FXI

SPY

TSLA

The U.S. House Republican Chair has requested details regarding Tesla's relationship with Chinese battery manufacturer CATL, according to a letter cited by Reuters.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 7:53 pm

ADSK

AVGO

BLK

CSCO

INTC

JPM

LMT

MMM

PYPL

TSLA

UBS

S&P 500 companies are increasingly investing in politically aligned nations, sidestepping China, according to a Bloomberg Economics analysis. The study found that cost-effectiveness is no longer the primary factor for companies investing abroad. Instead, companies are more likely to make significant investments in like-minded countries. In 2022, $1.2 trillion were made in greenfield foreign direct investments (FDI), with $180 billion (or 15%) shifting from countries not condemning Russia's invasion of Ukraine to those who did. Companies including BlackRock, Coca-Cola, Tesla, 3M, Paypal, JP Morgan Chase, Citigroup, Lockheed Martin, Broadcom, Cisco Systems, Intel, Mastercard, Ford, UBS Group, and Autodesk have mentioned 'geopolitics' more frequently in earnings calls.

Portfolio Pulse from Natan Ponieman

September 19, 2023 | 7:38 pm

SPY

U.S. House Republicans have failed to advance defense spending, raising concerns about a potential government shutdown. This could impact the overall market, including ETFs like SPY.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 7:32 pm